Insider Sale Alert: Travere Therapeutics Inc [TVTX] – Is it Time to sell?

Travere Therapeutics Inc’s filing revealed that its CHIEF FINANCIAL OFFICER Cline Christopher R. unloaded Company’s shares for reported $364.0 on Apr 11 ’24. In the deal valued at $6.74 per share,54 shares were sold. As a result of this transaction, Cline Christopher R. now holds 70,849 shares worth roughly $0.45 million. Then, Dube Eric M […]

Travere Therapeutics Inc [TVTX] stock for 166,435 USD was sold by Dube Eric M

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Travere Therapeutics Inc shares valued at $166,435 were sold by Dube Eric M on Feb 01 ’24. At $8.70 per share, Dube Eric M sold 19,122 shares. The insider’s holdings dropped […]

Travere Therapeutics Inc (TVTX) receives a Neutral rating from Guggenheim

In a filing, Travere Therapeutics Inc revealed its CHIEF EXECUTIVE OFFICER Dube Eric M unloaded Company’s shares for reported $0.17 million on Feb 01 ’24. In the deal valued at $8.70 per share,19,122 shares were sold. As a result of this transaction, Dube Eric M now holds 350,600 shares worth roughly $2.44 million. Then, REED […]

Travere Therapeutics Inc [TVTX] Records 200-Day SMA of $10.18

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Travere Therapeutics Inc shares valued at $166,435 were sold by Dube Eric M on Feb 01 ’24. At $8.70 per share, Dube Eric M sold 19,122 shares. The insider’s holdings dropped to 350,600 shares […]

Citigroup upgrades Travere Therapeutics Inc (TVTX) rating to a Buy

ZOM Stock

Travere Therapeutics Inc’s recently made public that its CHIEF EXECUTIVE OFFICER Dube Eric M unloaded Company’s shares for reported $0.17 million on Feb 01 ’24. In the deal valued at $8.70 per share,19,122 shares were sold. As a result of this transaction, Dube Eric M now holds 350,600 shares worth roughly $2.76 million. Then, REED […]